Catalyst Wire Dossier Catalyst Wire Dossier

F230 tablets

F230 · Beijing Continent Pharmaceutical Co, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for F230 tablets, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Preliminary Human Trials of F230 Tablets [Phase 1]

See pricing